Tisotumab_Vedotin

Introduction: What is Tisotumab Vedotin?

Tisotumab vedotin is a targeted cancer therapy designed to treat specific types of cancer, particularly advanced or metastatic cervical cancer. It is an antibody-drug conjugate that combines a monoclonal antibody with a cytotoxic drug, allowing for a more precise attack on cancer cells while minimizing damage to healthy tissues.

Uses of Tisotumab Vedotin

Tisotumab vedotin is approved for adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

How Does It Work?

Tisotumab vedotin works by targeting cancer cells that express the tissue factor protein. The human monoclonal IgG1 antibody specific to tissue factor (TF) binds to the tissue factor on the surface of cancer cells. Once attached, the drug is internalized, and the cytotoxic agent is released inside the cancer cell, leading to cell death. This mechanism allows for a more focused attack on cancer cells while sparing normal cells, which is a significant advantage over traditional chemotherapy.

Dosage and Administration

The standard dosage of tisotumab vedotin for adults is administered as an intravenous (IV) infusion. The recommended dose is 2 mg/kg (up to 200 mg) as an IV infusion for over 30 minutes once every 3 weeks. It is crucial to follow the healthcare provider's instructions regarding dosage and administration to ensure safety and efficacy.

Side Effects of Tisotumab Vedotin

Like all medications, tisotumab vedotin can cause side effects. Common side effects include:

• Fatigue
• Nausea
• Vomiting
• Diarrhea
• Hair loss
• Skin rash

Serious side effects may include:

• Ocular adverse reactions (e.g., blurred vision, corneal issues)
• Infusion-related reactions
• Peripheral neuropathy (numbness or tingling in hands and feet)
• Pneumonia
• Fatal hemorrhage

Patients should report any unusual or severe side effects to their healthcare provider immediately.

Drug Interactions

Tisotumab vedotin may interact with other medications, which can affect how it works or increase the risk of side effects. Major drug interactions include:

• Anticoagulants or antiplatelets (blood thinners)
• Strong CYP3A4 inhibitors/inducers

It is essential for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid potential interactions.

Benefits of Tisotumab Vedotin

The use of tisotumab vedotin offers clinical advantages based on evidence:

• Clinical trials (innovaTV 204) showed a 24% objective response rate (ORR) vs 0% placebo.
• Targeted therapy reduces damage to healthy cells.

Contraindications of Tisotumab Vedotin

Certain individuals should avoid using tisotumab vedotin, including:

• Pregnancy (contraindicated); breastfeeding is not recommended, as it may harm the infant.
• Patients with active or prior severe hepatic impairment (bilirubin >3x ULN).
• Individuals with a known hypersensitivity to tisotumab vedotin or any of its components.

A thorough medical history and evaluation by a healthcare provider are essential before starting treatment.

Precautions and Warnings

Before starting tisotumab vedotin, patients should undergo specific lab tests to assess liver function and overall health. Patients should undergo an ophthalmic exam before each dose and use cold pack prophylaxis for eyes during/after infusion. It is crucial to monitor any signs of infusion-related reactions during administration. Patients should also be advised to report any vision changes or neurological symptoms promptly, as these may indicate serious side effects.

FAQs

1. What is tisotumab vedotin used for? Tisotumab vedotin is used to treat recurrent or metastatic cervical cancer in adults after progression on or after chemotherapy, particularly in patients whose tumors express tissue factor.
2. How is tisotumab vedotin administered? It is administered as an intravenous infusion every 3 weeks.
3. What are the common side effects? Consult with your healthcare provider about all the medications you are taking to avoid potential interactions.
4. Can I take other medications with tisotumab vedotin? No specific dietary restrictions per prescribing information but maintaining a healthy diet can help manage side effects.
5. Is tisotumab vedotin safe during pregnancy? No, it is contraindicated in pregnant women due to potential harm to the fetus.
6. How does tisotumab vedotin work? It targets cancer cells expressing tissue factor, delivering a cytotoxic drug directly to kill those cells.
7. What should I do if I experience side effects? Report any unusual or severe side effects to your healthcare provider immediately.
8. Is there a specific diet I should follow while on tisotumab vedotin? There are no specific dietary restrictions, but maintaining a healthy diet can help manage side effects.
9. How long will I need to be on tisotumab vedotin? Treatment duration varies based on individual response and disease progression, as determined by your healthcare provider.
10. Can tisotumab vedotin be used in children? It is not approved for pediatric patients.

Brand Names

Tisotumab vedotin is marketed under the brand name Tivdak. It is essential to consult with a healthcare provider for more information on availability and potential alternatives.

Conclusion

As with any medication, it is crucial to discuss potential benefits and risks with a healthcare provider to ensure the best possible care.